152 research outputs found
Proceedings of the American Society of Mechanical Engineers, ASME Internal Combustion Engine Division\u27s 2013 Fall Technical Conference
No full textShahrokh Etemad (with Benjamin Baird) is a contributing author, Advanced Technology Igniter for High Power Density Engines
World Heavy Oil Congress 2011: Proceedings of a meeting held 14-17 March 2011
No full textShahrokh Etemad (with J.G. Weissman, B. Baird, S. Alavandi, and W. C. Pfefferle) is a contributing author, “Novel Down-Hole Combustor for Steam Generation”
Proceedings of ASME Turbo Expo 2013: Power for Land, Sea and Air, Volume 1A: Combustion, Fuels and Emissions
No full textShahrokh Etemad (with Sandeep Alavandi and Benjamin Baird) is a contributing author, Fuel Flexible Rich Catalytic Lean Burn System for Low Btu Fuels
Proceedings of the ASME 2014 Internal Combustion Engine Division Fall Technical Conference. Volume 1: Large Bore Engines; Fuels; Advanced Combustion; Emissions Control Systems
No full textShahrokh Etemad (with Richard Mastanduno and Subir Roychoudhury) is a contributing author, Onboard Hydrogen Generation for IC Engine Emissions Reduction.https://digitalcommons.fairfield.edu/engineering-books/1040/thumbnail.jp
Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions
No full textObstructive sleep apnea (OSA) is highly prevalent among patients with asymptomatic left ventricular systolic and diastolic dysfunction and congestive heart failure, and if untreated may contribute to the clinical progression of heart failure (HF). Given the health and economic burden of HF, identifying potential modifiable risk factors such as OSA and whether appropriate treatment improves outcomes is of critical importance. Identifying the subgroups of patients with OSA and HF who would benefit most from OSA treatment is another important point. This focused review surveys current knowledge of OSA and HF in order to provide: (1) a better understanding of the pathophysiologic mechanisms that may increase morbidity among individuals with HF and comorbid OSA, (2) a summary of current observational data and small randomized trials, (3) an understanding of the limitations of current larger randomized controlled trials, and (4) future needs to more accurately determine the efficacy of OSA treatment among individuals with HF
- …
